Catheter Precision VTAK
NYSE VTAK
$0.20 -0.01 (-4.76%)
At close: Aug 20, 2026 · 4:00 PM EDT

Catheter Precision (VTAK) Long-Term Investments (2025)

Catheter Precision (VTAK) posted quarterly Long-Term Investments of $874000.0 for Q2 2025.

Catheter Precision (VTAK) Long-Term Investments (2025) Analysis & Trends

Catheter Precision (VTAK) has reported Long-Term Investments for 1 consecutive years, with $874000.0 the latest figure, recorded in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 1.11 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 2.25 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 244.10 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 175.52 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 Catheter Precision 564,834.50 -1.27 Mn 98,000.00 -

Historic Data

Download Data
DateValue
Jun 30, 2025 874,000.00